The present invention relates to 2-adamantylurea derivatives of formula (I) asselective inhibitors of the enzyme11-beta-hydroxysteroid dehydrogenase type 1(110-HSD1) and the use of suchcompounds for the treatment and prevention ofmetabolic syndrome, diabetes, insulin resistance, obesity, lipid disorders,glaucoma, osteoporosis, cognitive disorders, anxiety,depression, immune disorders, hypertension and other diseases and conditions.